28P-27438-92189
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 740 / OK
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 1 — Pfizer-BioNTech
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
-
2021-03-03
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis — Feeling: FairFree text: Developed symptoms of a mild head cold late last night, which have persisted throughout today. I dont believe them to be related to the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis — Feeling: FairFree text: Still dealing with mild head cold symptoms, likely unrelated to the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — day 7, dose 1MedDRA: Nasopharyngitis — Feeling: FairFree text: Mild head cold symptoms, likely unrelated to the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-06-18
-
2021-09-17
Survey response — 6 months, dose 2MedDRA: Cough, Pyrexia, Quarantine, Respiratory tract infection, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for COVID-19 earlier this week, but had been self-isolating since last week due to the illness. Symptoms include moderate respiratory infection with cough. Fever onset about a week after initial symptoms, but comes and goes.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Developed symptoms of a mild head cold late last night, which have persisted throughout today. I dont believe them to be related to the vaccine.
Systemic reaction (other): Still dealing with mild head cold symptoms, likely unrelated to the vaccine
Release 5 — day 7, dose 1
Systemic reaction (other): Mild head cold symptoms, likely unrelated to the vaccine
Release 9 — 6 months, dose 2
Symptoms: Tested positive for COVID-19 earlier this week, but had been self-isolating since last week due to the illness. Symptoms include moderate respiratory infection with cough. Fever onset about a week after initial symptoms, but comes and goes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release